PAINWeek Premiere 9/30

While pain management education is needed more than ever, for the safety of faculty and attendees, we have postponed our live PAINWeekEnd Regional Conferences until 2021. Meanwhile, we are pleased to announce that we are launching a new educational webinar series, PAINWeek Premiere, which will provide 3.0 CE/CME credit hours. Beginning on September 16, they will be presented twice per week—on alternating Wednesdays and Saturdays (except preceding/following holidays).

If you have not registered for PWLVC, or registered for only the live virtual portion, you can register for this September 30^th activity for $99. However, it’s not too late to either subscribe or upgrade your current PWLVC package to receive the added value of additional CE/CME activities for FREE. Contact us at (973) 415-5100 for information on how to upgrade.
Subscribers have access to 120 CE/CME credit hours PLUS additional PAINWeek Premiere activities presented throughout the year.

*If you have already registered for the PAINWeek 2020 Live Virtual Enduring Conference (PWLVC) and on demand subscription, PAINWeek Premiere is FREE. Contact us at (973) 415-5100 to register for the September 30^th activity.

12:00p

1:00p

Everybody’s Greasing Up, But Should You Rub It In?
A Review of Topical Analgesics and Available Evidence in Clinical Trials

Faculty Timothy J. Atkinson

Topical analgesics are often recommended in clinical practice, but differences between formulations and routes of administration lead to confusion. In addition to commercially prepared topical analgesics, compounded topical analgesics are highly promoted and widely utilized from compounding pharmacies with individualized recipes of multiple combined medications, at substantial cost. To assist providers with tough decisions in this area, the available clinical trials supporting use will be reviewed along with formulations, locations, and doses where their use have been shown to the be most effective. This session will review the role of various topical analgesics as well as explore the rationale for “topical polypharmacy” with compounded drugs.

UAN 0530-0000-20-028-L01-P
Rx hours 0.10

1:00p

2:00p

Opioid Moderatism: Seeking Middle Ground

Faculty Michael E. Schatman

Few would question the severity of the prescription opioid crisis of the early years of this millennium, the causes of which were myriad. Undoubtedly, society needed to address the crisis in an aggressive manner. Unfortunately, the manner in which the problem was addressed has been a classic example of “overkill,” resulting in a war on opioid analgesia, the patients who require opioid treatment, and the providers who have continued to prescribe. Although many have cast blame on the 2016 CDC Opioid Prescribing Guideline, it was not necessarily the Guideline itself that caused so much suffering, but rather its weaponization. Irrespective, patients have been the “collateral damage” in this war on opioids. This presentation will address the imperative of physicians exercising more thorough and consistent opioid risk mitigation in order to avoid opioid analgesia from becoming further “legislated away,” as well as the imperative of those who are “pro-opioid” and “anti-opioid” to agree on a rational middle ground that is more “pro-patient.”

UAN 0530-0000-20-047-L04-P
Rx hours 0.0

2:00p

3:00p

The Other Opioid Crisis: Heroin and Fentanyl

Faculty Kevin L. Zacharoff

There is a significant amount of media, political, and public attention paid to the opioid crisis/opioid epidemic in the United States today. With the seemingly ever-increasing number of opioid-related overdoses and fatalities, there has been a feverish push by stakeholders to diminish the amount of opioids prescribed in order to help stem these worrisome trends. Unfortunately, there may be a lack of focus regarding the true definition and characterization of the opioid epidemic. There may also be a rush to judgment about the role of appropriately prescribed opioid analgesics in the addiction crisis we face today as well. This presentation will discuss the roles and statistics of both prescription and illicit opioids (namely heroin and fentanyl) in today’s “opioid overdose epidemic” with the intention of clarifying important differences and similarities between these competing epidemics including concerns and clinical considerations specific to each of them. Additionally, this program will examine and identify how these medications and drugs share potentially tragic adverse effect profiles in many cases. However, it is important for clinicians to make sure that appropriate chronic pain patients that may be candidates for opioid analgesic therapy aren’t penalized, and still get the treatment that they deserve.

UAN 0530-0000-20-044-L04-P
Rx hours 0.0

3:00p

3:15p

Faculty Q&A

Program Guide

Click here to download the program guide for this webinar.

This activity is provided by Global Education Group.

Target Audience

The educational design of this activity addresses the needs of frontline clinicians: physicians, nurses, nurse practitioners, physician assistants, and pharmacists involved in managing acute and chronic pain.

Statement of Need/Program Overview

Whether you're in a hospital or office-based practice, chronic pain patients are everywhere--and YOU are absorbing the burden of their care.

A just released report by the National Institutes of Health outlines positive steps that practitioners can take in response to the burgeoning problem of prescription medication abuse and to provide more effective pain management care to their patients. Key among these is access to pain education, and by participating in a PAINWeekEnd Conference, you'll improve your skills in medication risk evaluation and mitigation, in pain assessment and diagnosis, and in the delivery of individualized multimodal treatment.

The PAINWeekEnd agenda is purposely constructed for the busy clinician, delivering a full day of relevant, practical information, together with the opportunity for interaction and exchange with faculty and fellow attendees.

Pain Management for the Main Street Practitioner has been created to streamline the clutter of information on assessment, evolving guidelines, risk management, and changing reimbursement scenarios. Join us for a day of clinical and practice management CE/CME designed expressly for frontline clinicians. Participants can receive 3.0 AMA PRA Category 1 Credits™ as they expand their capabilities in the assessment, diagnosis, and management of chronic pain conditions.

Learning Objectives

Discuss the rationale for compounded topical analgesics
Explain the benefit of a comprehensive and consistent opioid risk mitigation platform
Discuss common beliefs and inconsistencies about the role of prescription opioids in the opioid crisis

Physician Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

* This CE/CME activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioner Continuing Education

Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 3.0 contact hour(s) (which includes 0.10 hour(s) of pharmacology).

Nursing Credit Designation

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 6.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 3 hours of Category 1 credit for completing this program.

Pharmacy Credit Designation

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 3.0 contact hours (0.3 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge-based activity.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must attend the courses. Web link to credit application and evaluation form will be emailed to participants the following week. Once completed, participants will be able to immediately download/print their certificates. Pharmacy learners will have their credits uploaded directly to NABP within 60 days of completion.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Patrick Kelly prior to the live event at (973) 415-5109.

For information about the accreditation of this program, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN—Nothing to disclose
Kristin Delisi, NP—Nothing to disclose
Andrea Funk—Nothing to disclose
Lindsay Borvansky—Nothing to disclose
Liddy Knight—Nothing to disclose

September 30, 2020

Program Information

The Speakers

Agenda

Program Guide

CE/CME and Accreditation

Target Audience

Statement of Need/Program Overview

Learning Objectives

Physician Accreditation Statement

Physician Credit Designation

ABIM MOC Recognition Statement

Nurse Practitioner Continuing Education

Nursing Credit Designation

Physician Assistants

Pharmacy Credit Designation

Instructions to Receive Credit

Disclosure of Conflicts of Interest

Americans With Disabilities Act

Disclosure of Conflicts of Interest